Regulatory impairment in untreated Parkinson’s disease is not restricted to Tregs: other regulatory populations are also involved
Authors:
Open Access
- 11 November 2019
- journal article
- research article
- Published by Springer Nature in Journal of Neuroinflammation
- Vol. 16 (1) , 1-11
Abstract
Background: Parkinson’s disease (PD) is the second most common neurodegenerative disease in the world. Various studies have suggested that the immune response plays a key role in this pathology. While a predominantly pro-inflammatory peripheral immune response has been reported in treated and untreated PD patients, the study of the role of the regulatory immune response has been restricted to regulatory T cells. Other immune suppressive populations have been described recently, but their role in PD is still unknown. This study was designed to analyze the pro and anti-inflammatory immune response in untreated PD patients, with emphasis on the regulatory response.Methods: Thirty-two PD untreated patients and 20 healthy individuals were included in this study. Peripheral regulatory cells (CD4+Tregs, Bregs, CD8+Tregs, and tolerogenic dendritic cells), pro-inflammatory cells (Th1, Th2, and Th17 cells; active dendritic cells), and classical, intermediate, and non-classical monocytes were characterized by flow cytometry. Plasmatic levels of TNF-α, IFN-γ, IL-6, GM-CSF, IL-12p70, IL-4, IL-13, IL-17α, IL-1β, IL-10, TGF-β, and IL-35 were determined by ELISA.Results: Decreased levels of suppressor Tregs, active Tregs, Tr1 cells, IL-10-producer CD8regs, and tolerogenic PD-L1+ dendritic cells were observed. With respect to the pro-inflammatory response, a decrease in IL-17-α and an increase in IL-13 levels were observed.Conclusion: A decrease in the levels of regulatory cell subpopulations in untreated PD patients is reported for the first time in this work. These results suggest that PD patients may exhibit a deficient suppression of the pro-inflammatory response, which could contribute to the pathophysiology of the disease.Keywords
Funding Information
- Secretaría de Ciencia, Humanidades, Tecnología e Innovación (2015-1-261455)
This publication has 59 references indexed in Scilit:
- Blood Dendritic Cell Frequency Declines in Idiopathic Parkinson’s Disease and Is Associated with Motor Symptom SeverityPLOS ONE, 2013
- Cysticerci Drive Dendritic Cells to PromoteIn VitroandIn VivoTregs DifferentiationJournal of Immunology Research, 2013
- Regulatory T‐lymphocytes mediate amyotrophic lateral sclerosis progression and survivalEMBO Molecular Medicine, 2012
- CD4+ Regulatory and Effector/Memory T Cell Subsets Profile Motor Dysfunction in Parkinson’s DiseaseJournal of Neuroimmune Pharmacology, 2012
- Diagnosis of Parkinson's Disease Based on Disease-Specific Autoantibody Profiles in Human SeraPLOS ONE, 2012
- Endogenous regulatory T lymphocytes ameliorate amyotrophic lateral sclerosis in mice and correlate with disease progression in patients with amyotrophic lateral sclerosisBrain, 2011
- Gender differences in Parkinson's disease: Clinical characteristics and cognitionMovement Disorders, 2010
- PD-L1 regulates the development, maintenance, and function of induced regulatory T cellsJournal of Experimental Medicine, 2009
- The role of CD8+CD28−regulatory cells in suppressing myasthenia gravis-associated responses by a dual altered peptide ligandProceedings of the National Academy of Sciences, 2007
- Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptidesJournal of Experimental Medicine, 2006